Repeat imaging at 612 months helps assess treatment response, with clinically meaningful improvement defined as at least a 30% relative reduction in hepatic fat content
Via several processes, including insulin and leptin resistance, perivascular adipose tissue dysfunction, reduced kidney function, activation of the renin-angiotensin-aldosterone system, and increased sympathetic nervous system activity, obesity can cause hypertension
That high demand has created a market for compounded versions of the weight loss drug
Some patients switch to compounded tirzepatide after experiencing side effects with brand-name versions, hoping that the added glycine and B12 will improve tolerability
The molecular mechanisms that justify the potential benefits of GLP-1 RA in IBD and the links between IBD, obesity, and cardiovascular disease are also discussed
It does not predict exact supplement toleranceclinical evaluation by your provider is essential for personalized guidance